We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2006 by Helsinki University.
Recruitment status was:  Active, not recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00298337
First Posted: March 2, 2006
Last Update Posted: October 18, 2006
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Helsinki University
  Purpose
The aim of the study is to find out if allergic diseases can be prevented buy giving probiotic bacteria to pregnant mothers and their newborn infants

Condition Intervention Phase
Atopic Dermatitis Food Hypersensitivity Allergic Rhinitis, Seasonal Allergic Conjunctivitis Asthma Drug: Mixture of probiotic bacteria and prebiotic oligosaccharide Phase 2 Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Prevention

Resource links provided by NLM:


Further study details as provided by Helsinki University:

Study Start Date: October 1999
Estimated Study Completion Date: December 2007
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   37 Weeks to 42 Weeks   (Child)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

  • mother or father fo child with doctor diagnoses allergic disease

Exclusion Criteria:

  • prematurity, major malformations
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00298337


Locations
Finland
Helsinki University Central Hospital, Skin and Allergy Hospital
Helsinki, PO box 160, Finland, 00029 HUS
Sponsors and Collaborators
Helsinki University
Investigators
Study Chair: Erkki Savilahti, Professor Helsinki University Central Hospital, Hospital for Children and Adults, PO Box 281, 00029 HUS, Finland
  More Information

Additional Information:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00298337     History of Changes
Other Study ID Numbers: T101060058;T1040A0002;T110612
First Submitted: March 1, 2006
First Posted: March 2, 2006
Last Update Posted: October 18, 2006
Last Verified: March 2006

Additional relevant MeSH terms:
Rhinitis
Dermatitis
Rhinitis, Allergic
Dermatitis, Atopic
Eczema
Hypersensitivity
Conjunctivitis
Conjunctivitis, Allergic
Food Hypersensitivity
Rhinitis, Allergic, Seasonal
Nose Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Otorhinolaryngologic Diseases
Skin Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Skin Diseases, Genetic
Genetic Diseases, Inborn
Skin Diseases, Eczematous
Conjunctival Diseases
Eye Diseases


To Top